• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸入用粘合剂混合物基础认识方面的最新进展。

Recent advances in the fundamental understanding of adhesive mixtures for inhalation.

作者信息

Grasmeijer Floris, Grasmeijer Niels, Hagedoorn Paul, Frijlink Henderik Willem, Haaije de Boer Anne

机构信息

University of Groningen, Department of Pharmaceutical Technology and Biopharmacy, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.

出版信息

Curr Pharm Des. 2015;21(40):5900-14. doi: 10.2174/1381612821666151008124622.

DOI:10.2174/1381612821666151008124622
PMID:26446471
Abstract

Adhesive mixtures for inhalation are the most widely used type of formulation in dry powder inhalation products. Although they have been the subject of active research, the relationships between properties of the starting materials, the mixing and dispersion processes, and the dispersion performance of this type of formulation are generally poorly understood. Interactions between relevant variables have been mentioned as an important cause. By reviewing the effects on mixture dispersion performance of the most widely studied formulation variables we try to find out whether or not the understanding of adhesive mixtures has improved in recent years. We furthermore propose an approach that may potentially accelerate the process of understanding. General conclusions concerning the effects of the variables considered cannot be drawn, because inconsistent findings are reported throughout the literature for all of them. These inconsistencies are indeed largely the result of interactions between variables of the formulation and dispersion processes. Mechanisms for most of the observed effects and interactions have been proposed, but they often remain unproven and, therefore, speculative. We have attempted to condense the knowledge from the literature into a theoretical framework that is intended to help explain the interplay between variables. According to this framework, only few mixture properties are key to understanding the effects of and interactions between formulation variables. Therefore, we suggest that the development or optimisation of techniques to accurately characterise these mixture properties could be an effective approach to further the fundamental understanding of adhesive mixtures for inhalation and enable their rational engineering.

摘要

吸入用粘合剂混合物是干粉吸入产品中使用最广泛的剂型。尽管它们一直是积极研究的对象,但对于这类制剂起始材料的性质、混合与分散过程以及分散性能之间的关系,人们普遍了解甚少。相关变量之间的相互作用被认为是一个重要原因。通过回顾研究最为广泛的制剂变量对混合物分散性能的影响,我们试图弄清楚近年来对粘合剂混合物的理解是否有所提高。此外,我们提出了一种可能会加速理解过程的方法。由于文献中针对所有这些变量都报道了不一致的结果,因此无法得出关于所考虑变量影响的一般性结论。这些不一致实际上很大程度上是制剂和分散过程变量之间相互作用的结果。对于大多数观察到的效应和相互作用的机制已经有人提出,但往往未经证实,因此具有推测性。我们试图将文献中的知识浓缩成一个理论框架,旨在帮助解释变量之间的相互作用。根据这个框架,只有少数混合物性质是理解制剂变量的影响及其相互作用的关键。因此,我们建议开发或优化准确表征这些混合物性质的技术,可能是进一步从根本上理解吸入用粘合剂混合物并实现其合理设计的有效方法。

相似文献

1
Recent advances in the fundamental understanding of adhesive mixtures for inhalation.吸入用粘合剂混合物基础认识方面的最新进展。
Curr Pharm Des. 2015;21(40):5900-14. doi: 10.2174/1381612821666151008124622.
2
The dispersion behaviour of dry powder inhalation formulations cannot be assessed at a single inhalation flow rate.干粉吸入制剂的分散行为不能在单一吸入流速下进行评估。
Int J Pharm. 2014 Apr 25;465(1-2):165-8. doi: 10.1016/j.ijpharm.2014.02.024. Epub 2014 Feb 15.
3
Drug content effects on the dispersion performance of adhesive mixtures for inhalation.药物含量对吸入用粘性混合物分散性能的影响。
PLoS One. 2013 Aug 14;8(8):e71339. doi: 10.1371/journal.pone.0071339. eCollection 2013.
4
A critical view on lactose-based drug formulation and device studies for dry powder inhalation: which are relevant and what interactions to expect?乳糖基药物制剂和干粉吸入装置研究的批判性观点:哪些是相关的,以及可以预期哪些相互作用?
Adv Drug Deliv Rev. 2012 Mar 15;64(3):257-74. doi: 10.1016/j.addr.2011.04.004. Epub 2011 Apr 23.
5
Development of a Rational Design Space for Optimizing Mixing Conditions for Formation of Adhesive Mixtures for Dry-Powder Inhaler Formulations.开发合理设计空间以优化干粉吸入剂配方中粘合剂混合物形成的混合条件。
J Pharm Sci. 2017 Jan;106(1):129-139. doi: 10.1016/j.xphs.2016.07.012. Epub 2016 Aug 18.
6
Powder Production and Particle Engineering for Dry Powder Inhaler Formulations.干粉吸入剂制剂的粉末生产与颗粒工程
Curr Pharm Des. 2015;21(27):3902-16. doi: 10.2174/1381612821666150820111134.
7
A review of factors affecting electrostatic charging of pharmaceuticals and adhesive mixtures for inhalation.影响吸入用药物和粘合剂混合物静电充电的因素综述。
Int J Pharm. 2016 Apr 30;503(1-2):262-76. doi: 10.1016/j.ijpharm.2016.01.076. Epub 2016 Feb 2.
8
Dry powder inhalation: past, present and future.干粉吸入:过去、现在与未来。
Expert Opin Drug Deliv. 2017 Apr;14(4):499-512. doi: 10.1080/17425247.2016.1224846. Epub 2016 Aug 30.
9
Relationships between surface coverage ratio and powder mechanics of binary adhesive mixtures for dry powder inhalers.干粉吸入器中二元粘性混合物的表面覆盖率与粉末力学之间的关系。
Int J Pharm. 2018 Apr 25;541(1-2):143-156. doi: 10.1016/j.ijpharm.2018.02.017. Epub 2018 Feb 15.
10
Single-use disposable dry powder inhalers for pulmonary drug delivery.一次性使用干粉吸入器用于肺部药物递送。
Expert Opin Drug Deliv. 2010 Dec;7(12):1359-72. doi: 10.1517/17425247.2010.538379. Epub 2010 Nov 17.

引用本文的文献

1
Feasibility of a High-Dose Inhaled Indomethacin Dry Powder with Dual Deposition for Pulmonary and Oral Delivery.高剂量吸入性吲哚美辛干粉双重沉积用于肺部和口服给药的可行性
Pharmaceutics. 2024 Sep 28;16(10):1269. doi: 10.3390/pharmaceutics16101269.
2
Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements.吸入剂型:聚焦干粉吸入器及其进展
Pharmaceuticals (Basel). 2023 Nov 28;16(12):1658. doi: 10.3390/ph16121658.
3
Spray-Congealing and Wet-Sieving as Alternative Processes for Engineering of Inhalation Carrier Particles: Comparison of Surface Properties, Blending and In Vitro Performance.
喷雾冷冻和湿筛作为吸入载体颗粒工程的替代工艺:表面性能、混合和体外性能的比较。
Pharm Res. 2021 Jun;38(6):1107-1123. doi: 10.1007/s11095-021-03061-5. Epub 2021 Jun 10.
4
On the relationship between blend state and dispersibility of adhesive mixtures containing active pharmaceutical ingredients.含活性药物成分的粘合剂混合物的混合状态与分散性之间的关系
Int J Pharm X. 2020 Dec 24;3:100069. doi: 10.1016/j.ijpx.2020.100069. eCollection 2021 Dec.
5
Novel approach for real-time monitoring of carrier-based DPIs delivery process pulmonary route based on modular modified Sympatec HELOS.基于模块化改进的Sympatec HELOS对基于载体的干粉吸入器经肺途径给药过程进行实时监测的新方法。
Acta Pharm Sin B. 2020 Jul;10(7):1331-1346. doi: 10.1016/j.apsb.2020.02.013. Epub 2020 Mar 4.
6
Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery.用于肺部给药的吸入纳米治疗药物的药代动力学
J Control Release. 2020 Oct 10;326:222-244. doi: 10.1016/j.jconrel.2020.07.011. Epub 2020 Jul 16.
7
Automated Filling Equipment Allows Increase in the Maximum Dose to Be Filled in the Cyclops High Dose Dry Powder Inhalation Device While Maintaining Dispersibility.自动灌装设备能够在保持分散性的同时,增加独眼巨人高剂量干粉吸入装置的最大灌装剂量。
Pharmaceutics. 2020 Jul 9;12(7):645. doi: 10.3390/pharmaceutics12070645.
8
Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities.纳米颗粒化疗药物的肺部给药用于肺癌治疗:挑战与机遇
Acta Pharmacol Sin. 2017 Jun;38(6):782-797. doi: 10.1038/aps.2017.34. Epub 2017 May 1.